• University of California, San Diego, B.S. chemistry (2004)
  • University of Zurich, M.Sc. chemistry (2006)
  • University of Zurich, Dr. sc. nat. organic chemistry (2011)
  • George Mason University, J.D. (2018)


  • District of Columbia
  • U.S. Patent and Trademark Office (USPTO)

Karla I. Arias, Dr. sc. nat.


Dr. Karla I. Arias is an associate in the Intellectual Property Group in Crowell & Moring's Washington, D.C. office.

Prior to joining Crowell & Moring, Karla worked at Carnegie Mellon University’s Institute for Green Science as a Swiss National Science Foundation postdoctoral fellow investigating the degradation of endocrine-disrupting contaminants in water and the formation and reactivity of iron complexes. 

Karla received her doctorate in organic chemistry at the University of Zurich, where her research focused on the synthesis of supramolecular architectures and the study of fluorescent and phosphorescent properties of supramolecular building blocks. In addition, Karla holds a M.Sc. in chemistry from the University of Zurich, focusing on organic chemistry, and a B.S. in chemistry from the University of California, San Diego.  

Karla has focused on patent prosecution and has used her scientific background to provide technical analysis in support of patent counseling, opinion work, and litigation for the chemical and pharmaceutical industries. 


Admitted to practice: District of Columbia, U.S. Patent and Trademark Office (USPTO)

Professional Activities and Memberships

  • HNBA/Microsoft Intellectual Property Law Institute (IPLI) Fellow

Representative Matters

  • Waters Tech., Inc. & Waters Corp., Inc. v. Agilent Techs., Inc., No. 18-1450-MN (D. Del.) – Representing Agilent in a patent infringement suit on N-glycan labeling reagent.
  • Secured a significant victory (a preliminary injunction against patent infringement through trial) on behalf of Lonza Walkersville, Inc. against Israel-based Adva Biotechnology Ltd. in a case involving point-of-care cell-therapy technology.


  • "Risk Allocation For Drug And Device Cos. And Their Suppliers," Law360 (February 12, 2021). Authors: Hilary Johnson, Karla I. Arias, and Emily Tucker.
  • "Removal of Ecotoxicity of 17a-ethinylestradiol using TAML/Peroxide Water Treatment," Scientific Reports, 5, 10511-10520 (2015). Co-Author: Karla I. Arias.
  • "Linear Bilateral Extended 2,2’:6’,2”-Terpyridine Ligands, Their Coordination Complexes, and Heterometallic Supramolecular Networks," Chemical Science, 5, 4317-4327 (2014). Co-Author: Karla I. Arias.
  • "Synthesis of a D3-Symmetric 'Trefoil' Knotted Cyclophane," Chemical Communications, 47, 9588-9590 (2011). Co-Author: Karla I. Arias.
  • "Synthesis of Arylbromides from Arenes and N-bromosuccinimide (NBS) in Acetonitrile – A Convenient Method for Aromatic Bromination," Canadian Journal of Chemistry, 87, 440-447 (2009). Co-Author: Karla I. Arias.

Client Alerts & Newsletters

Press Coverage

Firm News & Announcements

January 27, 2022 LITIGATION NOTE: Crowell & Moring Secures Preliminary Injunction for Lonza in Ground-Breaking Cell Therapy Patent Infringement Case
October 4, 2019 LITIGATION NOTE: Crowell & Moring Client Agilent Successfully Rebuts Preliminary Injunction Because Patent Likely Invalid